Medicare Advantage PPO out-of-pocket maximums in the city for combined in- and out-of-network services range from $9,000 to ...

The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...

A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly tripling in price.

Get Instant Summarized Text (Gist) Medicare Part D beneficiaries are facing higher out-of-pocket costs for brand name medications as drug plans increasingly use co-insurance tied to list prices ...

Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...